首页> 外文OA文献 >Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer
【2h】

Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer

机译:众包公众参与癌症大规模分子病理学研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Citizen science, scientific research conducted by non-specialists, has the potential to facilitate biomedical research using available large-scale data, however validating the results is challenging. The Cell Slider is a citizen science project that intends to share images from tumors with the general public, enabling them to score tumor markers independently through an internet-based interface. ududMethods: From October 2012 to June 2014, 98,293 Citizen Scientists accessed the Cell Slider web page and scored 180,172 sub-images derived from images of 12,326 tissue microarray cores labeled for estrogen receptor (ER). We evaluated the accuracy of Citizen Scientist's ER classification, and the association between ER status and prognosis by comparing their test performance against trained pathologists. ududFindings: The area under ROC curve was 0.95 (95% CI 0.94 to 0.96) for cancer cell identification and 0.97 (95% CI 0.96 to 0.97) for ER status. ER positive tumors scored by Citizen Scientists were associated with survival in a similar way to that scored by trained pathologists. Survival probability at 15. years were 0.78 (95% CI 0.76 to 0.80) for ER-positive and 0.72 (95% CI 0.68 to 0.77) for ER-negative tumors based on Citizen Scientists classification. Based on pathologist classification, survival probability was 0.79 (95% CI 0.77 to 0.81) for ER-positive and 0.71 (95% CI 0.67 to 0.74) for ER-negative tumors. The hazard ratio for death was 0.26 (95% CI 0.18 to 0.37) at diagnosis and became greater than one after 6.5. years of follow-up for ER scored by Citizen Scientists, and 0.24 (95% CI 0.18 to 0.33) at diagnosis increasing thereafter to one after 6.7 (95% CI 4.1 to 10.9) years of follow-up for ER scored by pathologists. ududInterpretation: Crowdsourcing of the general public to classify cancer pathology data for research is viable, engages the public and provides accurate ER data. Crowdsourced classification of research data may offer a valid solution to problems of throughput requiring human input.
机译:背景:公民科学是由非专家进行的科学研究,具有利用现有的大量数据促进生物医学研究的潜力,但是验证结果具有挑战性。 Cell Slider是一项公民科学项目,旨在与公众共享来自肿瘤的图像,使他们能够通过基于Internet的界面独立对肿瘤标志物进行评分。方法:从2012年10月到2014年6月,98,293名公民科学家访问了Cell Slider网页,并对来自标记有雌激素受体(ER)的12,326个组织微阵列核心图像的180172个子图像进行了评分。我们通过与经过培训的病理学家进行比较,评估了公民科学家ER分类的准确性以及ER状态与预后之间的关联。 ud ud发现:ROC曲线下的面积对于癌细胞鉴定为0.95(95%CI 0.94至0.96),对于ER状态为0.97(95%CI 0.96至0.97)。由公民科学家评分的ER阳性肿瘤与存活的相关性与受过训练的病理学家评分的相似。根据《公民科学家》分类,ER阳性的15年生存率分别为0.78(95%CI为0.76至0.80)和ER阴性肿瘤为0.72(95%CI为0.68至0.77)。根据病理学家分类,ER阳性的生存率是0.79(95%CI 0.77至0.81),ER阴性的肿瘤是0.71(95%CI 0.67至0.74)。诊断时死亡的危险比为0.26(95%CI为0.18至0.37),而在6.5之后大于1。由公民科学家评分的ER随访期为10年,诊断后为0.24(95%CI为0.18至0.33),此后由病理学家评分为6.7(95%CI为4.1至10.9)年ER随访后增加为1。 ud ud解释:大众众包分类癌症病理数据进行研究是可行的,可以吸引公众,并提供准确的ER数据。研究数据的众包分类可以为需要人工输入的吞吐量问题提供有效的解决方案。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号